Daniel Ward, MD
Orthopaedic Surgery · Chestnut Hill, MANPI 1922065820
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $282,480 of the $345,852 with a category attached, or 81.7%. Stryker accounts for 97.9% of it on its own, with 18 other manufacturers making up the rest. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $1149.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$339K
- EPI Health, LLC$6K
- Exactech, Inc.$231
- Pacira Therapeutics, Inc.$172
- Heron Therapeutics, Inc.$167
- Johnson & Johnson$131
- plus $595 from 13 others
What the payments were for
- Consulting fees$282,48082%
- Speaking & faculty fees$6,0002%
- Travel & lodging$43,46513%
- Food & beverage$10,2373%
- Education$3,6701%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 255 | $338,556 |
| EPI Health, LLC | 6 | $6,000 |
| Exactech, Inc. | 2 | $231 |
| Pacira Therapeutics, Inc. | 3 | $172 |
| Heron Therapeutics, Inc. | 7 | $167 |
| Johnson & Johnson(2 entities) | 7 | $131 |
| Smith+Nephew | 1 | $91 |
| KCI USA, Inc. | 1 | $87 |
| Bioventus LLC | 5 | $84 |
| Zimmer Biomet | 1 | $58 |
| Convatec Inc. | 2 | $44 |
| Fidia Pharma USA Inc. | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 2 | $40 |
| Heraeus Medical, LLC. | 2 | $38 |
| Encore Medical, LP | 1 | $26 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $25 |
| Baudax Bio Inc. | 1 | $21 |
| Medical Device Business Services, Inc. | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$150,505
- TRIATHLON$93,231
- TRIDENT$59,084
- TRITANIUM$35,256
- INSIGNIA$30,707
- RESTORATION$25,556
- MOTIONSENSE DIGITAL GONIOMETER$20,477
- ACCOLADE$20,305
- NEW PRODUCT DEVELOPMENT$14,015
- Verasense$11,055
- Sitavig$6,000
- Cloderm$6,000
- Minolira 105mg$6,000
- Minolira 135mg$6,000
- Rhofade$6,000
- AEQUALIS$2,970
- SECUR-FIT$660
- LOGICAL DUAL MOBILITY COCR LINER$199
- GMRS$123
- Zilretta$114
How this compares
$345,852 in reported general payments places this provider in the 95th percentile of 542 orthopaedic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 19 | $45 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Chestnut Hill
- Paul TornettaBoston$16.3M
- Thomas ThornhillBoston$12M
- Stephen MurphyRoxbury Crossing$8M
- Andrew FreibergBoston$5.9M
- Jon WarnerBoston$5.4M
- Wolfgang FitzBoston$3.7M
- Brian KwonWaltham$1.9M
- Simon ChaoNorth Easton$1.6M
- Scott SigmanNorth Chelmsford$1.4M
- Michael LangworthyNorth Dartmouth$715K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.